These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11128699)

  • 1. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of cevimeline on dry eye in patients with Sjögren's syndrome: a randomized, double-blind clinical study.
    Ono M; Takamura E; Shinozaki K; Tsumura T; Hamano T; Yagi Y; Tsubota K
    Am J Ophthalmol; 2004 Jul; 138(1):6-17. PubMed ID: 15234277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
    Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjogren's syndrome from the perspective of ophthalmology.
    Kuklinski E; Asbell PA
    Clin Immunol; 2017 Sep; 182():55-61. PubMed ID: 28476437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca.
    Petrone D; Condemi JJ; Fife R; Gluck O; Cohen S; Dalgin P
    Arthritis Rheum; 2002 Mar; 46(3):748-54. PubMed ID: 11920411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome. Controversies and progress.
    Fox RI
    Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Criteria for diagnosis of Sjögren's syndrome.
    Fox RI; Saito I
    Rheum Dis Clin North Am; 1994 May; 20(2):391-407. PubMed ID: 8016418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
    Ramos-Casals M; Tzioufas AG; Font J
    Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of cevimeline, a muscarinic M1 and M3 agonist, in the treatment of Sjögren's syndrome.
    Fox RI
    Adv Exp Med Biol; 2002; 506(Pt B):1107-16. PubMed ID: 12614037
    [No Abstract]   [Full Text] [Related]  

  • 12. Artificial saliva products and drugs to treat xerostomia.
    Wynn RL; Meiller TF
    Gen Dent; 2000; 48(6):630-6. PubMed ID: 12004654
    [No Abstract]   [Full Text] [Related]  

  • 13. A new medication for treatment of dry mouth in Sjögren's syndrome.
    al-Hashimi I; Taylor SE
    Tex Dent J; 2001 Apr; 118(3):262-6. PubMed ID: 11404944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sjögren's syndrome in dermatology.
    Fox RI; Liu AY
    Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine dysfunction in Sjogren's syndrome.
    Tzioufas AG; Tsonis J; Moutsopoulos HM
    Neuroimmunomodulation; 2008; 15(1):37-45. PubMed ID: 18667798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical significance of cevimeline hydrochloride in the treatment of dry mouth in patients with Sjögren's syndrome].
    Ogawa N; Shimoyama K; Karasawa H; Fukushima T; Masaki Y; Wano Y; Hirose Y; Sugai S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Oct; 27(5):330-7. PubMed ID: 15559322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Sjögren's syndrome-associated dry eye an evidence-based review.
    Akpek EK; Lindsley KB; Adyanthaya RS; Swamy R; Baer AN; McDonnell PJ
    Ophthalmology; 2011 Jul; 118(7):1242-52. PubMed ID: 21459453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of cevimeline hydrochloride on dry cough in Sjögren's syndrome].
    Nishinarita M; Hanzawa M; Iikuni N; Ota S
    Nihon Rinsho Meneki Gakkai Kaishi; 2004 Apr; 27(2):99-102. PubMed ID: 15164930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.